In fact, in our ARVC cohort, only 3/77 (4%) patients were carriers of a pathogenic DSG2 genetic variant, leading to the possibility that mutations in other proteins led to AIDA, but not anti-DSG2-ab generation. The gene discussed is DSG2; the disease is arrhythmogenic right ventricular cardiomyopathy.